Statin-Fibrate Combination Therapy

American Journal of Cardiology

Volumn 101, Issue 10, 2008, Pages 1521-

  Feeman Jr , William E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; SIMVASTATIN;

ACUTE HEART INFARCTION; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG INDICATION; HUMAN; HYPERLIPIDEMIA; LETTER; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; PRESCRIPTION; PRIORITY JOURNAL; RHABDOMYOLYSIS;

ANTILIPEMIC AGENTS; CLOFIBRIC ACID; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TREATMENT OUTCOME;

EID: 42749092517     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.01.025     Document Type: Letter

References (1)

1. Holoshitz N., Alsheikh-Ali A.A., and Karas R.H. Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use. Am J Cardiol 101 (2008) 95-97